Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)

Request an Appointment
Print

Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments that treat this condition

Areas that research this condition

Research

Mayo Clinic researchers are working to improve the diagnosis and treatment of MOGAD. Specific efforts include increasing the recognition on how to diagnose MOGAD and understanding its biology so that targeted treatments can be developed.

Read more about research in the Mayo Clinic Laboratories and in the Center for Multiple Sclerosis and Autoimmune Neurology.

Publications

See a list of publications by Mayo Clinic doctors on MOGAD on PubMed, a service of the National Library of Medicine.

Research Profiles

By Mayo Clinic Staff

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) care at Mayo Clinic

Request an appointment
Diagnosis & treatmentCare at Mayo Clinic
Jan. 03, 2024
Print

Related

Associated Procedures

News from Mayo Clinic

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)

Research: It's all about patients

[MUSIC PLAYING]

Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight.